results released last night:
third quarter Axiron sales revenue 5.2m vs second quarter 2.2m, these being the only full quarters since launch.
as we know the prices are subsidised during the launch phase so at this point i am not focussed on the dollar value, rather the launch trajectory which looks very impressive.
i haven't listened to the whole conf call, so if anyone picked up commentary on specific volumes/mkt penetration pls do share.
- Forums
- ASX - By Stock
- ACR
- eli lilly: 136% qtrly increase in axiron sales
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.8¢

eli lilly: 136% qtrly increase in axiron sales
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.366M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 883823 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 500697 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 883823 | 0.017 |
10 | 962673 | 0.016 |
6 | 1361882 | 0.015 |
2 | 140000 | 0.014 |
3 | 486850 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 500697 | 1 |
0.020 | 56617 | 4 |
0.021 | 111922 | 1 |
0.022 | 168642 | 2 |
0.023 | 381179 | 1 |
Last trade - 16.21pm 30/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable